| 前收市價 | 14.35 |
| 開市 | 12.09 |
| 買盤 | 12.55 |
| 賣出價 | 15.15 |
| 拍板 | 122.00 |
| 到期日 | 2024-05-31 |
| 今日波幅 | 11.83 - 12.09 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 20 |
Motley FoolThis Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.
Investor's Business DailyS&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Eli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all trading in or near buy zones. Medical stocks are often viewed as defensive growth stocks, because their growth is insulated from economic swings due to the government or insurance covering most of the costs. Eli Lilly is in a buy zone while weight-loss drug rival and fellow IBD Leaderboard member Novo Nordisk is setting up.
Investor's Business DailyNetflix Stock Faces Test Of Time As IBD 50 Oil Stock Nears 10-Bagger Status
As a stock's advance gets long in the tooth, shares may still form bases, but late-stage formations carry risks. Netflix stock and Novo Nordisk, two IBD 50 growth stocks, are in late-stage bases. The fourth or fifth bases in a long-term advance are more prone to failure than earlier patterns, mainly because it gets harder to extend gains the longer that shares keep rising.
